Nav: Home

Cytokine profile differentiating Old World and New World hantaviral infections

June 15, 2017

Hantavirus infection is acute zoonosis clinically manifesting in two forms: Hemorrhagic Fever with Renal Syndrome (HFRS), caused by Old World hantaviruses, and Hantavirus pulmonary syndrome (HPS), caused by New World hantaviruses. Mild form of HFRS, Nephropaia epidemica (NE), is diagnosed in Tatarstan region of Russia, while HPS is endemic in Americas. Humans become infected by inhaling virus contaminated aerosol of urine and feces. The pathogenesis of NE and HPS remains largely unknown. Endothelial cells are identified as the main target; however no cell damage due to virus replication has been documented. There is no single factor identified to explain the complexity of the NE and HPS pathogenesis; therefore, it has been suggested that "cytokine storm" may play crucial role in disease presentation.

In order to identify the serological markers distinguishing NE and HPS, team led by Dr Svetlana Khaiboullina (University of Nevada, Reno, USA) and Prof Albert Rizvanov (Kazan Federal University, Russia) initiated study of the cytokine profile of serum samples collected during early and late phases of HPS and NE. For that, a team of collaborators from Argentina, Japan, USA and Russia was established as part of Kazan Federal University Program of Competitive Growth (Project 5-100). This team included experts in HPS and NE diagnosis and clinical management, statistical analysis of OMICs, and experts in the disease pathogenesis. Serum levels of 48 cytokines were analyzed using Luminex multiplex magnetic bead-based antibody detection assay.

Overall, HPS serum cytokine profile revealed more proinflammatory status in HPS cases as compared to NE. Furthermore, HPS was characterized by exclusively upregulated serum cytokine levels, with no cytokines being downregulated. On the contrary, NE cases were characterized by dichotomy in serum cytokine level. Additionally, we have found that severe form of hantavirus zoonosis, HPS, is characterized by higher number of cytokines upregulated (total of 40) as compared to NE, where only 21 cytokines were upregulated. Taken together, our analysis of serum cytokine profile in HPS and NE cases suggests that although HPS and NE share many characteristic features, there are distinct cytokine markers separating these diseases. These markers include: 1. severe inflammatory response in HPS cases, where interleukin 18 (IL18) may play the key role; 2. remarkable activation of Th1 type of immune response in HPS cases as compared to NE; 3. strong activation of innate immune response, especially NK cells in HPS cases as compared to NE. HPS and NE serum cytokine profile presents evidence to suggest degradation of extracellular matrix, increased mononuclear leukocyte proliferation and transendothelial migration.
Results of research published in Frontiers in Immunology, 18 May 2017.

This study was supported by Russian Science Foundation grant 15-14-00016.

Kazan Federal University

Related Immune Response Articles:

Discovering the early age immune response in foals
Researchers at the Cornell University College of Veterinary Medicine have discovered a new method to measure tiny amounts of antibodies in foals, a finding described in the May 16 issue of PLOS ONE.
Nixing the cells that nix immune response against cancer
For first time, study characterizes uptick of myeloid-derived suppressor cells in the spleens of human cancer patients, paving the way for therapies directed against these cells that collude with cancer.
Jumbled chromosomes may dampen the immune response to tumors
How well a tumor responds to immunotherapy may depend in part on whether its chromosomes are intact or in a state of disarray, a new study reports.
Tailored organoid may help unravel immune response mystery
Cornell and Weill Cornell Medicine researchers report on the use of biomaterials-based organoids in an attempt to reproduce immune-system events and gain a better understanding of B cells.
Tweaking the immune response might be a key to combat neurodegeneration
Patients with Alzheimer's or other neurodegenerative diseases progressively loose neurons yet cannot build new ones.
More Immune Response News and Immune Response Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...